Pregnancy-Induced Sweet's Syndrome Treated with Infliximab

9Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective: To present a case of relapsing and resistant Sweet's syndrome that developed during pregnancy together with an onset of Crohn's disease, showing complete resolution with the use of infliximab. Clinical Presentation and Intervention: A 30-year-old pregnant woman presented with fever, skin lesions, and diarrhea. Skin biopsy confirmed neutrophilic dermatosis and she was diagnosed with Crohn's disease after endoscopy. There was no recurrence of Sweet's syndrome outside of her pregnancy. During a previous pregnancy, while corticosteroids were ineffective, complete regression of skin lesions was achieved using infliximab. Conclusion: The "off-label" use of infliximab is beneficial for relapsing and resistant Sweet's syndrome.

Cite

CITATION STYLE

APA

Smolovic, B. D., Gajic-Veljic, M. D., Nikolic, M. M., & Muhovic, D. F. (2019). Pregnancy-Induced Sweet’s Syndrome Treated with Infliximab. Medical Principles and Practice, 28(2), 196–198. https://doi.org/10.1159/000494974

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free